Document reference

2020/0128(COD)  
Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease  
Basic information  

2020/0128(COD)

COD - Ordinary legislative procedure (ex-codecision procedure)
Regulation


Subject
3.10.09.06 Agro-genetics, GMOs
4.20.02.06 Clinical practice and experiments
4.20.04 Pharmaceutical products and industry

Legislative priorities
The EU’s response to the Covid-19 pandemic

Status

Procedure completed

 

Key players  
Key events  
17/06/2020
Legislative proposal published
19/06/2020
Committee referral announced in Parliament, 1st reading/single reading
01/07/2020
Decision by committee, without report
10/07/2020
Decision by Parliament, 1st reading/single reading
15/07/2020
Act adopted by Council after Parliament's 1st reading
15/07/2020
Final act signed
15/07/2020
End of procedure in Parliament
17/07/2020
Final act published in Official Journal
Technical information  
Procedure reference
2020/0128(COD)
Procedure type
COD - Ordinary legislative procedure (ex-codecision procedure)
Procedure subtype
Legislation
Legislative instrument
Regulation
Legal basis
Treaty on the Functioning of the EU TFEU 168-p4; Treaty on the Functioning of the EU TFEU 114-p1; Rules of Procedure EP 163
Mandatory consultation of other institutions
Stage reached in procedure
Procedure completed
Committee dossier
ENVI/9/03351
Documentation gateway  
Final act